Research peptides

Small-molecule NNMT inhibitor studied for cellular energy expenditure and fat-cell metabolism.

1mg · 5mg · 10mg

Modified fragment of human growth hormone (176–191 region) studied for fat metabolism.

2mg · 5mg · 10mg · 20mg

Gastric pentadecapeptide studied extensively for tendon, ligament, muscle and gut repair models.

2mg · 5mg · 10mg · 15mg

Tetrapeptide studied for telomerase activation and pineal-ageing models.

5mg · 10mg · 15mg · 20mg · 50mg

Copper tripeptide studied for skin remodelling, collagen synthesis and wound repair.

5mg · 10mg · 20mg · 30mg · 50mg

Skin-focused stack of GHK-Cu, BPC-157 and TB-500 studied for rejuvenation research.

10mg · 35mg · 50mg · 60mg · 70mg

Selective ghrelin-receptor agonist studied for pulsatile GH release with minimal off-target activity.

2mg · 5mg · 10mg

Non-selective melanocortin agonist studied for tanning and libido endpoints.

10mg

Mitochondrial-derived peptide studied for exercise-mimetic metabolic signalling.

5mg · 10mg · 15mg · 20mg

Core redox coenzyme studied for cellular-energy and ageing endpoints.

5mg · 10mg · 20mg · 50mg · 100mg

Melanocortin-4 receptor agonist studied for sexual-arousal pathways.

5mg · 10mg

Triple agonist of the GLP-1, GIP and glucagon receptors, studied for body-weight and metabolic outcomes.

5mg · 10mg · 20mg · 30mg · 50mg

Tuftsin-derived anxiolytic peptide studied for stress and attention endpoints.

5mg · 10mg · 15mg

GLP-1 receptor agonist widely studied for appetite regulation and glycaemic control.

1mg · 2mg · 5mg · 8mg · 10mg

ACTH(4-10) analogue developed in Russian research for cognition and neuroprotection studies.

2mg · 5mg · 10mg

Synthetic version of the actin-binding region of thymosin beta-4, studied for tissue repair and flexibility.

2mg · 5mg · 10mg · 15mg

Stabilised GHRH analogue studied for visceral fat reduction and GH-axis restoration.

2mg · 5mg · 10mg

Thymic peptide studied for T-cell maturation and immune modulation.

5mg · 10mg · 20mg · 30mg

Dual GIP/GLP-1 receptor agonist studied for weight management and insulin sensitivity.

5mg · 10mg · 15mg · 20mg · 30mg

Recovery stack combining BPC-157 and TB-500 in a single vial.

5mg · 10mg · 15mg · 20mg

Soluble ActRIIB decoy receptor studied for binding myostatin and related ligands.

1mg

Locally-acting follistatin-based fusion protein studied for site-specific muscle growth.

1mg

Full-length adrenocorticotropic hormone used in HPA-axis research.

1mg

Copper tripeptide studied for hair-follicle and skin research.

10mg · 50mg

Erythropoietin-derived peptide studied for tissue protection and small-fibre neuropathy models.

2mg · 5mg · 10mg

PTHrP analogue studied for anabolic bone-density endpoints.

2mg · 3mg

Dilute acetic acid solution used to dissolve acid-soluble peptides.

10ml

Adamantane-modified Semax derivative explored in nootropic research.

5mg

Proapoptotic peptidomimetic studied for targeting the blood supply of adipose tissue.

2mg · 5mg · 10mg

AMPK activator studied in exercise-endurance and metabolic research.

50mg

Acetylated carnitine studied for mitochondrial energy metabolism and cognitive endpoints.

500mg

Single-chain relaxin analogue studied for anti-fibrotic activity.

2mg · 5mg

Sterile water with 0.9% benzyl alcohol for reconstituting lyophilised peptides.

10ml · 30ml

Khavinson tetrapeptide studied in bronchial-tissue research.

10mg · 20mg

Specialist research peptide with an emerging literature.

5mg

Long-acting GHRH analogue whose drug-affinity complex extends half-life to days in research models.

2mg · 5mg · 10mg

Short-acting GHRH analogue studied for physiological GH pulse amplification.

2mg · 5mg · 10mg

Long-acting amylin analogue studied for satiety signalling, often discussed alongside GLP-1 agonists.

5mg · 10mg

Khavinson tripeptide studied in cartilage and connective-tissue research.

10mg · 20mg

Porcine-derived neuropeptide preparation studied in neurorecovery research.

10mg · 60mg

Khavinson tetrapeptide studied in cortical-tissue research.

10mg · 20mg

Khavinson tripeptide studied in immune-ageing research.

10mg · 20mg

Nonapeptide studied for sleep architecture and stress-axis modulation.

2mg · 5mg · 10mg

Frog-skin heptapeptide with high mu-opioid receptor affinity, studied in receptor pharmacology.

5mg

GnRH super-agonist studied in veterinary and endocrine research.

2mg

Angiotensin IV-derived small molecule studied for c-Met signalling and synaptogenesis.

5mg · 10mg

Erythropoiesis-stimulating hormone, a reference compound in red-cell research.

3000iu

D-retro-inverso FOXO4 peptide studied for selective senescent-cell clearance.

5mg · 10mg

Activin-binding protein studied as a myostatin antagonist in muscle research.

1mg

C-terminal fragment of growth hormone studied for lipolytic activity without GH-like effects on glucose.

2mg · 5mg

Myostatin-pathway research compound studied in muscle-growth regulation.

1mg

Myostatin protein used as a reference in muscle-signalling research.

1mg

Growth-hormone-releasing peptide studied for strong GH secretion with some appetite signalling.

2mg · 5mg · 10mg

First-generation GHRP studied for GH release and pronounced ghrelin-like appetite effects.

5mg · 10mg · 20mg

Master antioxidant tripeptide central to redox balance and detoxification research.

200mg · 600mg · 1500mg

GnRH agonist studied for pituitary desensitisation dynamics.

2mg

Synthetic GnRH used to probe the hypothalamic-pituitary-gonadal axis.

2mg · 5mg · 10mg

Human chorionic gonadotropin, a reference compound in reproductive-axis research.

5000iu

Recombinant human growth hormone, the reference compound of GH research.

10iu

Human menopausal gonadotropin studied in fertility research.

75iu

Potent GHRP analogue studied for GH release and cardioprotective signalling.

2mg · 5mg · 10mg

Mitochondrial-derived peptide studied for cytoprotection in ageing research.

5mg · 10mg

Truncated IGF-1 variant studied for potent, short-lived local growth signalling.

1mg

Extended IGF-1 analogue with reduced binding-protein affinity, studied for growth signalling.

1mg

GLOW stack extended with KPV for combined skin and gut research.

40mg · 50mg · 70mg · 80mg

Alpha-MSH tripeptide fragment studied for anti-inflammatory activity in gut and skin models.

2mg · 4mg · 5mg · 10mg

Hypothalamic peptide studied as the upstream trigger of the reproductive hormone axis.

5mg · 10mg

Amino-acid derivative central to fatty-acid transport into mitochondria.

500mg

Human cathelicidin antimicrobial peptide studied for innate immunity and wound repair.

2mg · 5mg

Daily GLP-1 receptor agonist with a long research record in appetite and glucose studies.

5mg · 10mg

IGF-1 splice variant expressed after mechanical loading, studied for muscle repair signalling.

2mg · 5mg

Alpha-MSH analogue studied for melanogenesis with selective MC1R activity.

10mg

Cosmetic signal peptide studied for collagen stimulation in skin models.

10mg

Dual GLP-1/glucagon receptor agonist in research for weight and lipid outcomes.

5mg · 10mg

Modified GRF(1-29) tetra-substituted GHRH fragment studied alongside GHRPs.

2mg · 5mg

Acetylated Epitalon variant studied for improved stability.

5mg · 10mg

Acetylated Selank variant studied for enhanced stability.

5mg · 10mg

Acetylated Semax variant studied for improved stability in nootropic research.

5mg · 10mg

Hypothalamic wakefulness neuropeptide studied in arousal and narcolepsy research.

5mg

Second orexin isoform studied for OX2 receptor signalling in sleep-wake research.

5mg

Neurohypophyseal hormone studied in bonding, stress and social-behaviour research.

2mg · 5mg · 10mg

CNTF-derived peptidomimetic studied for neurogenesis and synaptic-density endpoints.

5mg

Spadin-derived peptide studied for TREK-1 modulation in neuro-regeneration research.

2mg · 5mg

PEGylated mechano growth factor with an extended half-life in research settings.

2mg · 4mg · 5mg

p53-derived membrane-targeting peptide studied in cancer-cell selectivity research.

5mg

Khavinson tripeptide studied for brain-cell resilience in ageing research.

10mg · 20mg

ERR agonist described as an "exercise mimetic" in metabolic research.

5mg · 10mg

Octapeptide studied topically for expression-line reduction via SNARE-complex modulation.

10mg

Mitochondria-targeted tetrapeptide studied for cardiolipin binding and mitochondrial function.

5mg · 10mg · 20mg · 25mg · 50mg

GHRH(1-29) analogue with a long clinical research history in GH-axis studies.

2mg · 5mg · 10mg

Glucagon/GLP-1 dual agonist studied for obesity and liver-fat endpoints.

5mg · 10mg

Full-length thymosin beta-4 protein studied for wound healing and cell migration.

5mg · 10mg

Thyrotropin-releasing hormone used in thyroid-axis research.

5mg · 10mg

PTH(1-34) fragment studied for bone-formation signalling.

2mg

Thymus-extract peptide complex studied in immune-restoration research.

10mg · 20mg

Neuropeptide studied for immune modulation and airway biology.

5mg · 10mg

Khavinson tripeptide studied in vascular-ageing research.

10mg · 20mg

Khavinson dipeptide studied in immuno-ageing research.

10mg · 20mg